Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
57 studies found for:    "Romano-Ward syndrome" OR "Long QT Syndrome"
Show Display Options
Rank Status Study
1 Completed The Long QT Syndrome in Pregnancy
Condition: Long QT Syndrome
Intervention:
2 Recruiting Long QT Syndrome Screening in Newborns
Condition: Long QT Syndrome
Intervention: Device: QTScreen ECG Recorder
3 Recruiting The Canadian National Long QT Syndrome Registry
Condition: Long QT Syndrome
Intervention:
4 Recruiting Prospective Identification of Long QT Syndrome in Fetal Life
Condition: Long QT Syndrome
Intervention:
5 Recruiting Multicenter Evaluation of Children and Young Adults With Genotype Positive Long QT Syndrome
Condition: Long QT Syndrome
Intervention:
6 Not yet recruiting Effect of Grapefruit on QT Interval in Healthy Volunteers and Patients With Congenital Long QT Syndrome
Condition: Long QT Syndrome
Interventions: Drug: Moxifloxacin;   Dietary Supplement: Grapefruit group
7 Active, not recruiting Effect of Eleclazine on Shortening of the QT Interval, Safety, and Tolerability in Adults With Long QT Syndrome Type 3
Condition: Long QT Syndrome Type 3
Interventions: Drug: Eleclazine;   Drug: Eleclazine placebo
8 Recruiting Comparison Between Epinephrine and Exercise Test in QT Long Syndrome Patients
Condition: Long QT Syndrome Type 1 or 2
Interventions: Other: exercise test;   Other: Epinephrine test
9 Recruiting Abnormal QT-Response to the Sudden Tachycardia Provoked by Standing in Individuals With Drug-induced Long QT Syndrome
Condition: Long QT Syndrome
Intervention: Device: tilt table
10 Completed Effect of Oral GS-6615 on Dofetilide-Induced QT Prolongation, Safety, and Tolerability in Healthy Adults
Condition: Long QT Syndrome
Interventions: Drug: GS-6615;   Drug: Placebo to match GS-6615;   Drug: Placebo to match dofetilide;   Drug: Dofetilide
11 Recruiting Long Term Prophylactic Therapy of Congenital Long QT Syndrome Type III (LQT3) With Ranolazine
Condition: Long QT Syndrome Type 3
Intervention: Drug: Ranolazine
12 Completed Study of the Effect of GS-6615 in Subjects With LQT-3
Condition: Long QT Syndrome
Intervention: Drug: GS-6615
13 Completed Pharmacokinetics of Eleclazine in Adults With Normal and Impaired Hepatic Function
Condition: Long QT Syndrome
Intervention: Drug: Eleclazine
14 Recruiting Efficacy Study of Sodium Channel Blocker in LQT3 Patients
Condition: Long QT Syndrome
Interventions: Drug: Placebo;   Drug: Ranolazine
15 Recruiting Long QT and Hearing Loss Registry
Conditions: Sensorineural Hearing Loss;   Long QT Syndrome
Intervention:
16 Recruiting Genetics of QT Prolongation With Antiarrhythmics
Conditions: Long QT Syndrome;   Drug Toxicity
Intervention: Drug: Dofetilide and/or sotalol
17 Active, not recruiting Metabolism of Patients With Genetically Caused Cardiac Arrhythmia
Condition: Long QT Syndrome
Intervention:
18 Completed Pharmacokinetics of Eleclazine in Adults With Normal and Impaired Renal Function
Condition: Long QT Syndrome
Intervention: Drug: Eleclazine
19 Completed QT-prolongation in Psychiatric Hospitals
Condition: QT-prolongation
Intervention: Drug: drugs linked with QT-prolongation
20 Completed Drug Interactions With Risk of QT-prolongation in a General Hospital
Condition: QT-prolongation
Intervention: Drug: Haloperidol

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.